Locoregional radiotherapy in patients with breast cancer responding to neoadjuvant chemotherapy: A paradigm for treatment individualization

Journal of Clinical Oncology

Volumn 32, Issue 6, 2014, Pages 494-495

  White, Julia ^a   Mamounas, Eleftherios ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b M D ANDERSON CANCER CENTER ORLANDO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AXILLARY LYMPH NODE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL DECISION MAKING; DISEASE FREE SURVIVAL; HUMAN; LOCOREGIONAL RADIOTHERAPY; LOW RISK POPULATION; LYMPH NODE METASTASIS; MASTECTOMY; META ANALYSIS (TOPIC); NOTE; OVERALL SURVIVAL; PARTIAL MASTECTOMY; PERSONALIZED MEDICINE; PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; TREATMENT RESPONSE; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ARTICLE; BREAST TUMOR; FEMALE; METHODOLOGY; PATHOLOGY; TREATMENT OUTCOME;

BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; INDIVIDUALIZED MEDICINE; LYMPHATIC METASTASIS; NEOADJUVANT THERAPY; RADIOTHERAPY, ADJUVANT; TREATMENT OUTCOME;

EID: 84898543187     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2013.53.4974     Document Type: Note

References (9)

1. Clarke M, Collins R, Darby S, et al: Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. Lancet 366:2087-2106, 2005
2. Marks LB, Prosnitz LR: Reducing local therapy in patients responding to preoperative systemic therapy: Are we outsmarting ourselves? J Clin Oncol 32:491-493, 2014
3. Fowble BL, Einck JP, Kim DN, et al: Role of postmastectomy radiation after neoadjuvant dhemotherapy in stage II-III breast cancer. Int J Radiat Oncol Biol Phys 83:494-503, 2012
4. Overgaard M, Nielsen HM, Overgaard J: Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 B & C randomized trials. Radiother Oncol 82:247-253, 2007 (Pubitemid 46350797)
5. Ragaz J, Olivotto IA, Spinelli JJ, et al: Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst 97:116-126, 2005 (Pubitemid 40277091)
6. Darby S, McGale P, Correa C, et al: Effect of radiotherapy after breastconserving surgery on 10-year recurrence and 15-year breast cancer death: Metaanalysis of individual patient data for 10,801 women in 17 randomized trials. Lancet 378:1707-1716, 2011
7. Rastogi P, Anderson SJ, Bear HD, et al: Preoperative chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27. J Clin Oncol 26:778-785, 2008 (Pubitemid 351264391)
8. Mamounas EP, Anderson SJ, Dignam JJ, et al: Predictors of locoregional recurrence after neoadjuvant chemotherapy: Results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27. J Clin Oncol 30:3960-3966, 2012
9. McGuire SE, Gonzales-Angulo AM, Huang EH, et al: Postmastectomy radiation improves the outcome of patients with locally advanced breast cancer who achieve a pathologically complete response to neoadjuvant chemotherapy. Int J Radiat Oncol Biol Phys 68:1004-1009, 2007 (Pubitemid 47048565)